Pfizer and BioNTech Announce U.S. FDA Approval of their COVID-19 Vaccine COMIRNATY®
… For Adolescents 12 through 15 Years of Age COMIRNATY® is the first and only COVID-19 vaccine to be granted FDA approval for adolescents 12 […]
COVID-19
Pfizer and BioNTech Submit a Variation to EMA
…. for the Vaccination of Children Ages 6 Months to less than 5 Years with COMIRNATY® Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: […]
Statement on Patent Infringement Lawsuit in Germany
BioNTech values and respects valid intellectual property rights. BioNTech’s work is original, and we will vigorously defend it against all allegations of patent infringement. However, […]
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety […]
Antibody Response to Omicron…
and Other Virus Variants Effectively Replenished after 3rd and 4th COVID-19 Vaccination 12 / 2022 Two vaccinations with Comirnaty do not lead to adequate antibody […]
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Submission based on real-world safety and efficacy data from Israel Data showed rates of confirmed infections were 2 times lower and rates of severe illness […]
FAO, OIE and WHO on monitoring SARS-CoV-2 infection in wildlife + preventing the formation of animal reservoirs
By Food and Agriculture Organization (FAO), World Organisation for Animal Health (OIE) and World Health Organization (WHO) As we enter the third year of the […]
WHO Director-General’s opening remarks at announcement “spokes” of mRNA technology transfer hub
Your Excellency President Macron,Excellency President Macky Sall,Excellency President Abdel Fattah Al-Sisi,Excellency President Kenyatta,Excellency President Buhari,Excellency President Saied,Excellency President Michel,Excellency President von der Leyen,Excellencies, dear colleagues, […]
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
Developing turnkey solution to enable mRNA-based vaccine production in modular and scalable sites installed by BioNTech Presidents of Ghana, Rwanda, Senegal, the Director-General of the […]
WHO – Essential health services face continued disruption during COVID-19 pandemic
Two years into the pandemic, health systems are still facing significant challenges in providing essential health services. Ongoing disruptions have been reported in over 90% […]
WHO: Information session on the mRNA vaccine technology transfer hub in South Africa
The audio file of today’s information session on the objectives, functioning and progress of the mRNA vaccine technology transfer hub in South Africa is available […]
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA
With pediatric COVID-19 cases surpassing 10 million and at the request of the FDA, the companies have submitted available data on the safety and efficacy […]
The Zika Virus´s Immune Escape Strategy
– Important Insights for the Development of Antiviral Therapies A research team led by the Paul-Ehrlich-Institut examined the interaction between the Zika virus and the […]
WHO Virtual Press Conference on COVID-19 and other global health issues, 18 January
WHO Director-General’s opening remarks at the media briefing on COVID-19 — 18 January 2022 The volcanic eruption near Tonga and subsequent tsunami requires an urgent […]
COVAX delivers its 1 billionth COVID-19 vaccine dose – with video
On 15 January 2021, a shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX. Together with our partners, COVAX […]